Towards a blood stage malaria vaccine, dealing with allelic polymorphism in the vaccine candidate apical membrane antihen 1

Leiden Repository

Towards a blood stage malaria vaccine, dealing with allelic polymorphism in the vaccine candidate apical membrane antihen 1

Title: Towards a blood stage malaria vaccine, dealing with allelic polymorphism in the vaccine candidate apical membrane antihen 1
Author: Kusi, Kwadwo Asamoah
Publisher: Faculty of Medicine / Leiden University Medical Center (LUMC), Leiden University
Issue Date: 2012-01-18
Keywords: Adjuvant
Allele
Antibody
Cross-strain
ELISA
Plasmodium falciparum
Strain-specific
Abstract: A vaccine against Plasmodium falciparum is needed to augment currently available malaria control tools. A handful of parasite antigens are at various stages of pre-clinical and clinical development. Amongst these is P. falciparum apical membrane antigen 1 (PfAMA1), an antigen expressed by asexual stage parasites and believed to be important for the parasite’s invasion of both red blood cells and liver cells. The immune response to PfAMA1 is mediated mainly by antibodies that prevent parasite invasion of host cells. PfAMA1 however shows allelic polymorphism, with anti-PfAMA1 antibody responses exhibiting strain-specificity. This thesis investigated multi-allele vaccine formulation strategies that would overcome the strain-specificity of antibody responses to PfAMA1. The main findings of this thesis are that i) different PfAMA1 alleles share epitopes to which functional cross-strain antibodies can be induced, ii) a three-allele PfAMA1 formulation yields the greatest proportion of functional cross-strain antibodies, and iii) three PfAMA1 alleles, irrespective of the adjuvant used for formulation and whether they are administrated as a multi-allele formulation or sequentially, induce similar proportions of cross-strain antibodies. Overall, a multi-allele formulation with three in silico-designed PfAMA1 candidates yields antibodies that inhibit several parasites in vitro and warrant their development as a human blood stage vaccine.
Description: Promotor: A.M. Deelder, Co-promotores: C.H.M. Kocken, E.J. Remarque
With summary in Dutch
Faculty: LUMC
Citation: Kusi, K.A., 2012, Doctoral thesis, Leiden University
ISBN: 9789461820501
Sponsor: BPRC-Rijswijk, BioGenes,GETFund, EMVI, EMVDA
Handle: http://hdl.handle.net/1887/18387
 

Files in this item

Description Size View
application/pdf Full text 2.800Mb View/Open
application/pdf Cover 919.1Kb View/Open
application/pdf Title page_Table of contents 74.35Kb View/Open
application/pdf Chapter 1 General introduction 1.038Mb View/Open
application/pdf Chapter 2 443.9Kb View/Open Full text at publisher site
application/pdf Chapter 3 406.7Kb View/Open Full text at publisher site
application/pdf Chapter 4 312.3Kb View/Open Full text at publisher site
application/pdf Chapter 5 311.9Kb View/Open Full text at publisher site
application/pdf Chapter 6 361.8Kb View/Open Full text at publisher site
application/pdf Chapter 7 160.1Kb View/Open
application/pdf Summary_Summary in Dutch 102.4Kb View/Open
application/pdf List of publica ... itae_Supplementary figures 245.9Kb View/Open
application/pdf Propositions 46.16Kb View/Open

This item appears in the following Collection(s)